Droplet digital recombinase polymerase amplification (ddRPA) reaction unlocking via picoinjection

Biosens Bioelectron. 2022 Apr 15:202:114019. doi: 10.1016/j.bios.2022.114019. Epub 2022 Jan 20.

Abstract

Recombinase polymerase amplification (RPA) has been recognized as a promising isothermal amplification method for nucleic acid detection. However, the digital format of RPA is still challenging to implement due to its MgOAc-initiated reaction feature and the inherent non-specific amplification. Here we develop a Picoinjection Aided Digital reaction unLOCKing (PADLOCK) approach utilizing droplet microfluidics to achieve droplet digital RPA (ddRPA) for absolute nucleic acid quantification. By coupling a microfluidic picoinjector with a droplet generator, the reaction initiator MgOAc is dosed into droplets containing MgOAc-deprived RPA master mix for controlled digital reaction unlocking, which completely circumvents premature amplification. The discretization of the targets to a single-molecule level in confined droplets endows absolute quantification of the copy number. Coupled with CRISPR/Cas13a sensing, the ddRPA demonstrates single molecule detection ability within 30 min with significantly enhanced signal-to-noise ratio (S/N ratio>6) and uniform fluorescence signal reporting, facilitating the precise quantification of nucleic acids. Furthermore, the utility of the PADLOCK-CRISPR assay has been validated with 22 clinical samples, which generated results in 100% concordance with qPCR. We believe the coupling of droplet microfluidic technology with digital RPA will pave the way towards ultrasensitive and precise nucleic acid quantification.

Keywords: Diagnostics; Digital quantification; Droplet microfluidics; Picoinjection; RPA.

MeSH terms

  • Biosensing Techniques*
  • Microfluidics
  • Nucleic Acid Amplification Techniques / methods
  • Nucleic Acids*
  • Recombinases

Substances

  • Nucleic Acids
  • Recombinases